8EM fundamentals
An in-depth look to Editas Medicine Inc. operating, investing, and financing activities
8EM free cash flow for Q2 24 is -56.54 M EUR. For 2023, 8EM free cash flow was -124.03 M EUR and operating cash flow was -119.75 M EUR.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM